These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1485 related articles for article (PubMed ID: 21219188)

  • 41. Specific NLRP3 inflammasome inhibitors: promising therapeutic agents for inflammatory diseases.
    Vong CT; Tseng HHL; Yao P; Yu H; Wang S; Zhong Z; Wang Y
    Drug Discov Today; 2021 Jun; 26(6):1394-1408. PubMed ID: 33636340
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genetic and Epigenetic Regulation of the Innate Immune Response to Gout.
    de Lima JD; de Paula AGP; Yuasa BS; de Souza Smanioto CC; da Cruz Silva MC; Dos Santos PI; Prado KB; Winter Boldt AB; Braga TT
    Immunol Invest; 2023 Apr; 52(3):364-397. PubMed ID: 36745138
    [TBL] [Abstract][Full Text] [Related]  

  • 43. NLRP12 in innate immunity and inflammation.
    Tuladhar S; Kanneganti TD
    Mol Aspects Med; 2020 Dec; 76():100887. PubMed ID: 32838963
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome.
    Shao A; Wu H; Hong Y; Tu S; Sun X; Wu Q; Zhao Q; Zhang J; Sheng J
    Mol Neurobiol; 2016 Jul; 53(5):3462-3476. PubMed ID: 26091790
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The inflammasome: an integrated view.
    Gross O; Thomas CJ; Guarda G; Tschopp J
    Immunol Rev; 2011 Sep; 243(1):136-51. PubMed ID: 21884173
    [TBL] [Abstract][Full Text] [Related]  

  • 46. NLRP7: From inflammasome regulation to human disease.
    Carriere J; Dorfleutner A; Stehlik C
    Immunology; 2021 Aug; 163(4):363-376. PubMed ID: 34021586
    [TBL] [Abstract][Full Text] [Related]  

  • 47. β-hydroxybutyrate suppresses NLRP3 inflammasome-mediated placental inflammation and lipopolysaccharide-induced fetal absorption.
    Hirata Y; Shimazaki S; Suzuki S; Henmi Y; Komiyama H; Kuwayama T; Iwata H; Karasawa T; Takahashi M; Takahashi H; Shirasuna K
    J Reprod Immunol; 2021 Nov; 148():103433. PubMed ID: 34628106
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inflammasome activation and metabolic disease progression.
    Li HB; Jin C; Chen Y; Flavell RA
    Cytokine Growth Factor Rev; 2014 Dec; 25(6):699-706. PubMed ID: 25156419
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The redox state of the alarmin HMGB1 is a pivotal factor in neuroinflammatory and microglial priming: A role for the NLRP3 inflammasome.
    Frank MG; Weber MD; Fonken LK; Hershman SA; Watkins LR; Maier SF
    Brain Behav Immun; 2016 Jul; 55():215-224. PubMed ID: 26482581
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inflammasomes and its importance in viral infections.
    Shrivastava G; León-Juárez M; García-Cordero J; Meza-Sánchez DE; Cedillo-Barrón L
    Immunol Res; 2016 Dec; 64(5-6):1101-1117. PubMed ID: 27699580
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The NLRP3 Inflammasome as a Pharmacological Target.
    Marchetti C
    J Cardiovasc Pharmacol; 2019 Oct; 74(4):285-296. PubMed ID: 31335445
    [TBL] [Abstract][Full Text] [Related]  

  • 52. NLRP3 Inflammasome: A Possible Link Between Obesity-Associated Low-Grade Chronic Inflammation and Colorectal Cancer Development.
    Ahechu P; Zozaya G; Martí P; Hernández-Lizoáin JL; Baixauli J; Unamuno X; Frühbeck G; Catalán V
    Front Immunol; 2018; 9():2918. PubMed ID: 30619282
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of NLRP3 Inflammasome Activation in Obesity-Mediated Metabolic Disorders.
    Wani K; AlHarthi H; Alghamdi A; Sabico S; Al-Daghri NM
    Int J Environ Res Public Health; 2021 Jan; 18(2):. PubMed ID: 33435142
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inflammasomes in the lung.
    Pinkerton JW; Kim RY; Robertson AAB; Hirota JA; Wood LG; Knight DA; Cooper MA; O'Neill LAJ; Horvat JC; Hansbro PM
    Mol Immunol; 2017 Jun; 86():44-55. PubMed ID: 28129896
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inflammasome in intestinal inflammation and cancer.
    Nunes T; de Souza HS
    Mediators Inflamm; 2013; 2013():654963. PubMed ID: 23606794
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inflammasome activation via intracellular NLRs triggered by bacterial infection.
    Koizumi Y; Toma C; Higa N; Nohara T; Nakasone N; Suzuki T
    Cell Microbiol; 2012 Feb; 14(2):149-54. PubMed ID: 21995284
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Human metapneumovirus activates NOD-like receptor protein 3 inflammasome via its small hydrophobic protein which plays a detrimental role during infection in mice.
    Lê VB; Dubois J; Couture C; Cavanagh MH; Uyar O; Pizzorno A; Rosa-Calatrava M; Hamelin MÈ; Boivin G
    PLoS Pathog; 2019 Apr; 15(4):e1007689. PubMed ID: 30964929
    [TBL] [Abstract][Full Text] [Related]  

  • 58. From Inflammasome to Exosome-Does Extracellular Vesicle Secretion Constitute an Inflammasome-Dependent Immune Response?
    Cypryk W; Nyman TA; Matikainen S
    Front Immunol; 2018; 9():2188. PubMed ID: 30319640
    [TBL] [Abstract][Full Text] [Related]  

  • 59. NLRP3 inflammasomes link inflammation and metabolic disease.
    De Nardo D; Latz E
    Trends Immunol; 2011 Aug; 32(8):373-9. PubMed ID: 21733753
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Beyond the inflammasome: regulatory NOD-like receptor modulation of the host immune response following virus exposure.
    Coutermarsh-Ott S; Eden K; Allen IC
    J Gen Virol; 2016 Apr; 97(4):825-838. PubMed ID: 26763980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 75.